Citation sources

Updated weekly. Details via Crossref
Crossref Scopus Google Scholar
17 14 Search
2025
Landscape of A-I RNA editing in mouse, pig, macaque, and human brains
Nucleic Acids Research
2025
A-to-I editing technologies: unlocking new avenues in cancer therapy
Journal of Scientific Reports-A
2025
Advances in neuroscientific mechanisms and therapies for glioblastoma
iScience
2024
Genetics of cell-type-specific post-transcriptional gene regulation during human neurogenesis
The American Journal of Human Genetics
2024
Emerging Roles and Mechanisms of RNA Modifications in Neurodegenerative Diseases and Glioma
Cells
2022
Neurotransmitters: Potential Targets in Glioblastoma
Cancers
2022
A Promising Glycolysis- and Immune-Related Prognostic Signature for Glioblastoma
World Neurosurgery
2022
Deep multilayer brain omics identifies the potential involvement of menopause molecular networks in Gliomas’ disease progression
The FASEB Journal
2022
RNA editing of ion channels and receptors in physiology and neurological disorders
Oxford Open Neuroscience
2022
Epitranscriptomic Modifications Modulate Normal and Pathological Functions in CNS
Translational Stroke Research
2022
Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
Frontiers in Pharmacology
2022
RNA Editing in Glioma as a Sexually Dimorphic Prognostic Factor That Affects mRNA Abundance in Fatty Acid Metabolism and Inflammation Pathways
Cells
2022
The role of RNA modification in the generation of acquired drug resistance in glioma
Frontiers in Genetics
2022
ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide
Scientific Reports
2021
Differential Analysis of A-to-I mRNA Edited Sites in Parkinson’s Disease
Genes
2021
RNA Editing: A New Therapeutic Target in Amyotrophic Lateral Sclerosis and Other Neurological Diseases
International Journal of Molecular Sciences
Additional cited-by details will be shown when available from Crossref